mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
0.0002 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.001 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |